Shareholders' Deficit (Details) - Schedule of Warrant Activities - Warrant [Member] - USD ($) |
9 Months Ended | |
|---|---|---|
Dec. 31, 2023 |
Sep. 30, 2024 |
|
| Schedule of Warrant Activities [Line Items] | ||
| Number of Warrants, Balance Outstanding, ending | 34,000,000 | 33,200,000 |
| Weighted Average Exercise Price, Balance Outstanding, ending | $ 0.011 | $ 0.01 |
| Weighted Average Remaining Contractual Term (Years), Balance Outstanding, ending | 2 years 8 months 23 days | 2 years 14 days |
| Aggregate Intrinsic Value, Balance Outstanding, ending | ||
| Number of Warrants, Exercisable | 33,200,000 | |
| Weighted Average Exercise Price, Exercisable | $ 0.01 | |
| Weighted Average Remaining Contractual Term (Years), Exercisable | 2 years 14 days | |
| Aggregate Intrinsic Value, Exercisable | ||
| Number of Warrants, Expired | (800,000) | |
| Weighted Average Exercise Price, Expired | ||
| Weighted Average Remaining Contractual Term (Years), Expired | ||
| Aggregate Intrinsic Value, Expired |
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of other than options award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of exercisable award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of expired award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Other increase (decrease) in number of shares reserved for issuance under non-option equity instrument agreements that is not separately disclosed. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of Exercisable award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of expired award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|